Understand the source comparison
Best Follistatin-344 Dosage Strength 2026: Protocol Comparison
Maintenance / Chronic Inhibition 100 mcg Once daily (subcutaneous) 14–28 days 60–70% sustained suppression Best for long-term studies tracking gradual hypertrophy markers; minimizes peptide cost while maintaining threshold activity Moderate Intervention 200 mc
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Maintenance / Chronic Inhibition
- 100 mcg
- Once daily (subcutaneous)
- 14–28 days
- 60–70% sustained suppression
- Best for long-term studies tracking gradual hypertrophy markers; minimizes peptide cost while maintaining threshold activity
- Moderate Intervention
- 200 mcg
- Once daily or split 100 mcg BID
- 7–14 days
- 75–82% suppression
- Split dosing recommended for time-averaged receptor occupancy; single daily dose acceptable for cost-limited protocols
- Acute / High-Intensity
- 300 mcg
- Once daily (IM preferred)
- 3–7 days
- 85–88% peak suppression
- Marginal gains over 200 mcg; reserve for studies requiring maximum inhibition during short intervention windows
- Cyclic Protocol
- Every other day
- 14–21 days
- 65–75% cyclic (peaks/troughs)
- Produces oscillating follistatin levels; useful for studying recovery kinetics but introduces variability